Zhicheng Du

CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model

Yu Yang Ng, Zhicheng Du, Xi Zhang et al. · Cancer Gene Therapy · 2021 · 94 citations

Medicine, Immunology, Oncology +12

piggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells

Zhicheng Du, Yu Yang Ng, Shijun Zha et al. · Molecular Therapy — Methods & Clinical Development · 2021 · 88 citations · Full text

Life Sciences, Immunology, Oncology +17

Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells

Shin Yi Tang, Shijun Zha, Zhicheng Du et al. · Stem Cell Research & Therapy · 2021 · 27 citations · Full text

Life Sciences, Biotechnology, Cell Biology +16

Dual CAR-T cells to treat cancers co-expressing NKG2D and PD1 ligands in xenograft models of peritoneal metastasis

Guangyi Jiang, Yu Yang Ng, Johan Chin-Kang Tay et al. · Cancer Immunology Immunotherapy · 2022 · 24 citations · Full text

Medicine, Immunology, Oncology +17

Manufacturing NKG2D CAR-T cells with piggyBac transposon vectors and K562 artificial antigen-presenting cells

Johan Chin-Kang Tay, Junjian Wang, Zhicheng Du et al. · Molecular Therapy — Methods & Clinical Development · 2021 · 23 citations · Full text

Life Sciences, Biotechnology, Immunology +17